Physician profile
Scott S Spore
NPI 1447334867
$6,534.46
in general payments reported to CMS, 2019-2025
39 companies · $458 in 2025
The $458 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $485 · 2021: $1,007 · 2022: $1,273 · 2023: $1,290 · 2024: $1,164 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,912.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,159.81 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $835.11 | 2019-2025 | Myrbetriq, Xtandi |
| Dendreon Pharmaceuticals LLC | $733.18 | 2019-2025 | Provenge |
| Axonics, INC. | $619.53 | 2021-2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $582.21 | 2021-2025 | |
| Abbvie INC. | $338.32 | 2021-2025 | Botox, Lupron Depot |
| Procept Biorobotics Corporation | $335.50 | 2020-2025 | Aquabeam System |
| Pfizer INC. | $277.81 | 2020-2025 | |
| Boston Scientific Corporation | $270.95 | 2019-2025 | Spaceoar System, Axonics, Bulkamid |
| Storz Medical America, INC. | $133.14 | 2023 | |
| Merck Sharp & Dohme LLC | $127.76 | 2021-2023 | Keytruda, Welireg, Lynparza |
| Sumitomo Pharma America, INC. | $111.54 | 2023-2025 | Gemtesa |
| Amgen INC. | $110.48 | 2019-2021 | |
| Urovant Sciences INC | $78.37 | 2021-2022 | |
| Srs Medical Systems, INC. | $72.02 | 2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Spore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.